[HTML][HTML] Hepatocellular carcinoma: state of the art imaging and recent advances

PJ Navin, SK Venkatesh - Journal of clinical and translational …, 2019 - ncbi.nlm.nih.gov
The incidence of hepatocellular carcinoma (HCC) is increasing, with this trend expected to
continue to the year 2030. Hepatocarcinogenesis follows a predictable course, which makes …

Reproducibility and repeatability of MR fingerprinting relaxometry in the human brain

G Körzdörfer, R Kirsch, K Liu, J Pfeuffer, B Hensel… - Radiology, 2019 - pubs.rsna.org
Background Only sparse literature investigates the reproducibility and repeatability of
relaxometry methods in MRI. However, statistical data on reproducibility and repeatability of …

Noninvasive staging of liver fibrosis: review of current quantitative CT and MRI-based techniques

WH Im, JS Song, W Jang - Abdominal Radiology, 2022 - Springer
Liver fibrosis features excessive protein accumulation in the liver interstitial space resulting
from repeated tissue injury due to chronic liver disease. Liver fibrosis eventually proceeds to …

T1 mapping, T2 mapping and MR elastography of the liver for detection and staging of liver fibrosis

DH Hoffman, A Ayoola, D Nickel, F Han… - Abdominal …, 2020 - Springer
Purpose To compare liver stiffness measurements obtained from MR elastography with liver
T1 relaxation times obtained from T1 mapping and T2 relaxation times obtained from T2 …

[HTML][HTML] Evaluation of liver fibrosis and cirrhosis on the basis of quantitative T1 mapping: Are acute inflammation, age and liver volume confounding factors?

HC Breit, KT Block, DJ Winkel, JE Gehweiler… - European Journal of …, 2021 - Elsevier
Purpose To evaluate potential confounding factors in the quantitative assessment of liver
fibrosis and cirrhosis using T1 relaxation times. Methods The study population is based on a …

T1 reduction rate with Gd-EOB-DTPA determines liver function on both 1.5 T and 3 T MRI

VC Obmann, D Catucci, A Berzigotti, C Gräni… - Scientific reports, 2022 - nature.com
Magnetic resonance T1 mapping before and after Gd-EOB-DTPA administration allows
quantification of the T1 reduction rate as a non-invasive surrogate marker of liver function. A …

T 1–T 2 dual-modal magnetic resonance contrast-enhanced imaging for rat liver fibrosis stage

F Lu, L Du, W Chen, H Jiang, C Yang, Y Pu, J Wu… - RSC …, 2022 - pubs.rsc.org
The development of an effective method for staging liver fibrosis has always been a hot topic
of research in the field of liver fibrosis. In this paper, PEGylated ultrafine superparamagnetic …

[HTML][HTML] Noninvasive imaging of hepatic dysfunction: a state-of-the-art review

T Duan, HY Jiang, WW Ling, B Song - World Journal of …, 2022 - ncbi.nlm.nih.gov
Hepatic dysfunction represents a wide spectrum of pathological changes, which can be
frequently found in hepatitis, cholestasis, metabolic diseases, and focal liver lesions. As …

Systematic review: The diagnostic efficacy of gadoxetic acid-enhanced MRI for liver fibrosis staging

D Yang, D Li, J Li, Z Yang, Z Wang - European journal of radiology, 2020 - Elsevier
Purpose To evaluate the diagnostic efficacy of gadoxetic acid-enhanced MRI for the staging
of liver fibrosis by meta-analysis. Methods PubMed/Medline, EMBASE, the Web of Science …

Quantitative susceptibility mapping versus R2*-based histogram analysis for evaluating liver fibrosis: preliminary results

M Yoshikawa, K Kudo, T Harada… - … Resonance in Medical …, 2022 - jstage.jst.go.jp
Purpose: The staging of liver fibrosis is clinically important, and a less invasive method is
preferred. Quantitative susceptibility mapping (QSM) has shown a great potential in …